99 related articles for article (PubMed ID: 16886577)
1. [Expression of blood coagulation inhibitors in colon cancer].
Sierko E; Zawadzki RJ; Zimnoch L; Sulkowski S; Wojtukiewicz MZ
Pol Merkur Lekarski; 2006 Apr; 20(118):462-7. PubMed ID: 16886577
[TBL] [Abstract][Full Text] [Related]
2. Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer.
Sierko E; Wojtukiewicz MZ; Zawadzki R; Zimnoch L; Kisiel W
Thromb Res; 2010 Mar; 125(3):e71-5. PubMed ID: 19818470
[TBL] [Abstract][Full Text] [Related]
3. Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Kisiel W
Thromb Haemost; 2010 Jan; 103(1):198-204. PubMed ID: 20062932
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
Thromb Res; 2012 Apr; 129(4):e112-8. PubMed ID: 22424030
[TBL] [Abstract][Full Text] [Related]
5. [Expression evaluation of in loco coagulation system in colorectal cancer].
Sierko E; Tokajuk P; Butkiewicz A; Sulkowski S; Zimnoch L; Wojtukiewicz MZ
Pol Merkur Lekarski; 2005 Feb; 18(104):176-9. PubMed ID: 17877125
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
7. [The location of components of fibrinolytic system in laryngeal cancer].
Sierko E; Tokajuk P; Zimnoch L; Wojtukiewicz MZ
Pol Merkur Lekarski; 2003 Jul; 15(85):81-5. PubMed ID: 14593967
[TBL] [Abstract][Full Text] [Related]
8. Indirect activation of blood coagulation in colon cancer.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Thromb Haemost; 1989 Dec; 62(4):1062-6. PubMed ID: 2694422
[TBL] [Abstract][Full Text] [Related]
9. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
10. The role of tissue factor pathway inhibitor-2 in cancer biology.
Sierko E; Wojtukiewicz MZ; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
[TBL] [Abstract][Full Text] [Related]
11. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
[TBL] [Abstract][Full Text] [Related]
13. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
14. [Hemostasis disorders in severe infections: state of the art].
Fourrier F
Med Mal Infect; 2006 Jun; 36(6):304-13. PubMed ID: 16713162
[TBL] [Abstract][Full Text] [Related]
15. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
16. The role of hemostatic system inhibitors in malignancy.
Wojtukiewicz MZ; Sierko E; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):621-42. PubMed ID: 18000789
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
18. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Calponin h1 expression in human colon cancer blood vessels.
Yanagisawa Y; Takeoka M; Ehara T; Itano N; Miyagawa S; Taniguchi S
Eur J Surg Oncol; 2008 May; 34(5):531-7. PubMed ID: 17707120
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue.
Wojtukiewicz MZ; Sierko E; Zimnoch L; Kozlowski L; Kisiel W
Thromb Haemost; 2003 Jul; 90(1):140-6. PubMed ID: 12876637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
